Heme/OncHigh-stakesPlaintiff-side

Built for chemo + febrile neutropenia + ICI cases.
AI deposition trainer with NCCN + IDSA + ASCO depth.

Heme/onc medmal cases concentrate around chemo dosing errors, febrile neutropenia antibiotic timing, TLS prophylaxis, transfusion reactions, and immune checkpoint inhibitor toxicity. NCCN + IDSA + ASCO define the floors.

Try the 2-min Heme/Onc demo → All specialties

Heme/Onc failure modes

cited guidelines

signature impeachment trap

Why a heme/onc-specific trainer matters

Heme/onc cases turn on documented BSA verification + cumulative dose tracking, within-hour empiric antibiotics for febrile neutropenia, TLS prophylaxis for high-risk patients, and irAE workup for ICI patients with new symptoms.

The 7 failure modes

Sev 10

Chemotherapy dosing error

Wrong BSA, wrong regimen, cumulative-dose limit exceeded.

"I'd have to look at the specific calculation."

Sev 10

Febrile neutropenia — empiric antibiotic delay

ANC<500 + fever; empiric antibiotics delayed >1 hour per IDSA.

"I was waiting for culture data."

Sev 9

Tumor lysis syndrome — no prevention

High-risk patient without rasburicase + aggressive hydration.

"I figured we'd watch labs closely."

Sev 9

Transfusion reaction recognition delay

Acute reaction; transfusion not stopped; product not returned.

"She had some chills — I gave Benadryl and continued."

Sev 8

ICI toxicity — irAE not recognized

irAE (colitis/pneumonitis/hepatitis) not recognized; steroids delayed.

"I figured it was viral."

Sev 8

Cancer staging — incomplete workup

Treatment without complete staging per NCCN; surgical decisions on incomplete data.

"We needed to start chemo quickly."

Sev 7

Malignancy-associated VTE — undertreatment

Cancer VTE with insufficient anticoag duration or wrong agent.

"I gave her warfarin — she was already on it."

The signature impeachment trap

"I figured it was viral" vs ICI toxicity workup

For ICI-toxicity cases: lock the witness into "I thought it was a routine illness," then juxtapose against the ASCO requirement that ICI patients with new symptoms receive immediate irAE workup.

"You thought her diarrhea was viral?" → "Yes."
"She was on immunotherapy at the time?" → "Yes."
"ASCO calls for ICI patients with new GI symptoms to receive immediate irAE workup?" → "Yes."
"Your chart does not document an irAE workup."

Why this lands: witness has framed a routine workup as adequate for an immune-modulated patient.

The 3 cited guidelines

NCCN Clinical Practice Guidelines in OncologyCancer-specific staging + treatment regimens + supportive care

IDSA Guidelines for Antimicrobial Use in Neutropenic PatientsFebrile neutropenia management + empiric coverage

ASCO + ASH Guidelines (irAE + cancer-VTE + TLS)Symptom-specific oncology guidelines for high-risk scenarios

FAQ

Why does heme/onc need its own deposition trainer?

Heme/onc cases turn on documented BSA + cumulative dose, within-hour FN antibiotics, TLS prophylaxis, and irAE workup. NCCN + IDSA + ASCO are real published floors.

What guidelines does the AI cite?

NCCN Clinical Practice Guidelines in Oncology, IDSA Neutropenia Guidelines, ASCO + ASH symptom-specific guidelines.

Does it work for defense expert prep?

Yes. Expert-prep mode against your defense oncologist.

Pricing?

Bundled in MedLegal AI Pro ($49/mo), Professional ($249/mo), or Firm ($499/mo).

Start with the 2-minute heme/onc demo

No signup, no mic. Cross-exam transfers to heme/onc — lock witness into NCCN + IDSA + ASCO standards.

Run the 2-min demo → Start free 14-day trial

Built for chemo + febrile neutropenia + ICI cases.AI deposition trainer with NCCN + IDSA + ASCO depth.